Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib

Saved in:
Bibliographic Details
Published in:Thoracic Cancer
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1869572615312506880
collection WordPress RSS
FRELIP Feed Integration
container_title Thoracic Cancer
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:98260
institution FRELIP
journal_source_facet Thoracic Cancer
last_indexed 2026-07-02T03:36:25.678Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib
title_alt Un estudio observacional de afatinib 30 mg diarios en pacientes con cáncer de pulmón de células no pequeñas avanzado con mutaciones comunes de EGFR tratados con afatinib
Étude observationnelle de l'afatinib 30 mg par jour chez des patients atteints d'un cancer du poumon non à petites cellules avancé portant des mutations courantes de l'EGFR traités par afatinib
Um Estudo Observacional de Afatinibe 30 mg Diário em Pacientes com Câncer de Pulmão de Células Não Pequenas Avançado Portadores de Mutações Comuns de EGFR Tratados com Afatinibe
title_auth An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib
title_es_txt Un estudio observacional de afatinib 30 mg diarios en pacientes con cáncer de pulmón de células no pequeñas avanzado con mutaciones comunes de EGFR tratados con afatinib
title_fr_txt Étude observationnelle de l'afatinib 30 mg par jour chez des patients atteints d'un cancer du poumon non à petites cellules avancé portant des mutations courantes de l'EGFR traités par afatinib
title_full An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib
title_fullStr An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib
title_full_unstemmed An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib
title_pt_txt Um Estudo Observacional de Afatinibe 30 mg Diário em Pacientes com Câncer de Pulmão de Células Não Pequenas Avançado Portadores de Mutações Comuns de EGFR Tratados com Afatinibe
title_short An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib
title_sort an observational study of afatinib 30 mg daily in patients with advanced non‐small‐cell lung cancer harboring common egfr mutations treated with afatinib
topic Oncology
General
Oncology
url https://onlinelibrary.wiley.com/doi/10.1111/1759-7714.70331?af=R